Dupilumab leads to no or low disease activity in most moderate-to-severe atopic dermatitis patients: signs, symptoms and quality of life

被引：0
|
作者：
Blauvelt, A. [1 ]
Chen, Z. [2 ]
Hultsch, T. [3 ]
Eckert, L. [4 ]
Gadkari, A. [2 ]
Shumel, B. [2 ]
Ardeleanu, M. [2 ]
机构：
[1] Oregon Med Res Ctr, Portland, OR USA
[2] Regeneron Pharmaceut, Tarrytown, NY USA
[3] Sanofi Genzyme, Cambridge, MA USA
[4] Sanofi, Chilly Mazarin, France
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2018年 / 179卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P079
引用
收藏
页码：60 / 60
页数：1
相关论文
共 50 条
  • [21] Dupilumab reduces inflammatory biomarkers in pediatric patients with moderate-to-severe atopic dermatitis
    Beck, Lisa A.
    Muraro, Antonella
    Boguniewicz, Mark
    Chen, Zhen
    Zahn, Joseph
    Marco, Ainara Rodriguez
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2025, 155 (01)
  • [22] Clinically meaningful responses in moderate-to-severe atopic dermatitis patients treated with Dupilumab
    de Bruin-Weller, M.
    Eckert, L.
    Simpson, E. L.
    Cork, M. J.
    Ardeleanu, M.
    Chen, Z.
    Shumel, B.
    Rossi, A. B.
    Graham, N. M. H.
    Pirozzi, G.
    Gadkari, A.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 116 - 116
  • [23] Dupilumab for moderate-to-severe atopic dermatitis: transformative changes in quality of life and low burden of treatment - a mixed-methods study
    Porter, Emma
    O'Connor, Cathal
    Murphy, Michelle
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [24] Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis
    Fargnoli, M. C.
    Esposito, M.
    Ferrucci, S.
    Girolomoni, G.
    Offidani, A.
    Patrizi, A.
    Peris, K.
    Costanzo, A.
    Malara, G.
    Pellacani, G.
    Romanelli, M.
    Amerio, P.
    Cristaudo, A.
    Flori, M. L.
    Motolese, A.
    Betto, P.
    Patruno, C.
    Pigatto, P.
    Sirna, R.
    Stinco, G.
    Zalaudek, I.
    Bianchi, L.
    Boccaletti, V.
    Cannavo, S. P.
    Cusano, F.
    Lembo, S.
    Mozzillo, R.
    Gallo, R.
    Potenza, C.
    Rongioletti, F.
    Tiberio, R.
    Grieco, T.
    Micali, G.
    Persechino, S.
    Pettinato, M.
    Pucci, S.
    Savi, E.
    Stingeni, L.
    Romano, A.
    Argenziano, G.
    Calabrese, Giulia
    Campanati, Anna
    Caruso, Cristiano
    Chello, Camilla
    De Pasquale, Tiziana
    Di Costanzo, Luisa
    Dini, Valentina
    De Pasquale, Rocco
    Del Giglio, Micol
    Fracassi, Giovanna
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2021, 32 (05) : 507 - 513
  • [25] COMPARING DERMATOLOGY LIFE QUALITY INDEX (DLQI) BETWEEN MODERATE-TO-SEVERE ATOPIC DERMATITIS PATIENTS AND MODERATE-TO-SEVERE PSORIASIS PATIENTS
    Kim, Yeong Ho
    Yoo, Seung Ah
    Han, Ju Hee
    Lee, Ji Hae
    Bang, Chul Hwan
    Lee, Young Bok
    Kim, Jung Eun
    Park, Hyun Jung
    Park, Chul Jong
    Lee, Ji Hyun
    Cho, Sang Hyun
    ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 20 - 20
  • [26] Efficacy of dupilumab in atopic comorbidities associated with moderate-to-severe adult atopic dermatitis
    Nettis, Eustachio
    Patella, Vincenzo
    Lombardo, Carla
    Detoraki, Aikaterini
    Macchia, Luigi
    Di Leo, Elisabetta
    Carbonara, Monica
    Canonica, Giorgio W.
    Bonzano, Laura
    ALLERGY, 2020, 75 (10) : 2653 - 2661
  • [27] LONG-TERM DUPILUMAB TREATMENT IMPROVES SIGNS AND SYMPTOMS IN KOREAN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS (LIBERTY AD ADULT OLE)
    Roh, Joo Young
    Park, Young Lip
    Park, Chun Wook
    Lee, Joo Hee
    Chen, Zhen
    Shumel, Brad
    Rossi, Ana B.
    ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 53 - 53
  • [28] Psoriasiform dermatitis during dupilumab treatment for moderate-to-severe atopic dermatitis in children
    Parker, Jennifer J.
    Sugarman, Jeffrey L.
    Silverberg, Nanette B.
    Gonzalez, Mercedes Elena
    Ramien, Michele L.
    Teng, Joyce M. C.
    Paller, Amy S.
    PEDIATRIC DERMATOLOGY, 2021, 38 (06) : 1500 - 1505
  • [29] Impact of dupilumab treatment on seasonal disease severity in adults with moderate-to-severe atopic dermatitis
    Beck, Lisa A.
    Simpson, Eric L.
    Ramien, Michele
    Tang, Mark
    Joyce, Joel C.
    Praestgaard, Amy
    Rossi, Ana B.
    Clearfield, Drew
    Zhang, Annie
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
  • [30] High dupilumab levels in tear fluid of atopic dermatitis patients with moderate-to-severe ocular surface disease
    Achten, Roselie
    Thijs, Judith
    van der Wal, Marlot
    van Luijk, Chantal
    van Luin, Matthijs
    el Amrani, Mohsin
    Knol, Edward
    Delemarre, Eveline
    Jager, Constance den Hartog
    de Graaf, Marlies
    Bakker, Daphne
    de Boer, Joke
    van Wijk, Femke
    de Bruin-Weller, Marjolein
    CLINICAL AND TRANSLATIONAL ALLERGY, 2023, 13 (01)
12345